MedTrace Logo

Survivorship Care Planning in Improving Quality of Life in Survivors of Ovarian Cancer

NCT02082470 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2017-09-28

No results posted yet for this study

Summary

This pilot clinical trial studies survivorship care planning in supporting quality of life in ovarian cancer survivors following primary treatment. Survivorship care plans have the potential to empower patients and provide them with a plan of care following treatments. Survivorship care planning may support patient's overall well-being and quality of life after treatment of ovarian cancer.

Conditions

  • Cancer Survivor
  • Stage IA Ovarian Epithelial Cancer
  • Stage IB Ovarian Epithelial Cancer
  • Stage IC Ovarian Epithelial Cancer
  • Stage IIA Ovarian Epithelial Cancer
  • Stage IIB Ovarian Epithelial Cancer
  • Stage IIC Ovarian Epithelial Cancer
  • Stage IIIA Ovarian Epithelial Cancer
  • Stage IIIB Ovarian Epithelial Cancer
  • Stage IIIC Ovarian Epithelial Cancer

Interventions

OTHER

follow-up care

Undergo survivorship care planning

OTHER

active surveillance

Undergo cancer surveillance

OTHER

questionnaire administration

Ancillary studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • City of Hope Medical Center

    lead OTHER

Principal Investigators

  • Virginia Sun · City of Hope Medical Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-11
Primary Completion
2017-09-26
Completion
2017-09-26

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02082470 on ClinicalTrials.gov